Team2024-10-24T16:13:38-04:00Lame Duck (New) Outlook Is SkinnyTeam2024-10-24T16:13:38-04:0010/22/2024|
Team2024-10-08T15:31:02-04:00Abbott and Edwards Lifesciences Likely Successful TCET CandidatesTeam2024-10-08T15:31:02-04:0010/07/2024|
Team2024-10-07T17:15:52-04:00Humana & United Challenge CMS on StarsTeam2024-10-07T17:15:52-04:0010/04/2024|
Team2024-10-07T17:11:35-04:002027 Negotiated Drug Prices Potentially Start Lower?Team2024-10-07T17:11:35-04:0010/03/2024|
Team2024-10-07T17:07:57-04:00FDA AdComm Reform is Not Coming Any Time SoonTeam2024-10-07T17:07:57-04:0010/02/2024|
Team2024-10-07T17:05:16-04:00Deja Vu: Healthcare Takes Backseat in Vance v. WalzTeam2024-10-07T17:05:16-04:0010/02/2024|
Team2024-09-30T17:02:05-04:00Medicare Advantage Landscape Files 2025Team2024-09-30T17:02:05-04:0009/29/2024|
Team2024-09-30T16:55:59-04:00Medicaid MCO Guidance On Prior AuthTeam2024-09-30T16:55:59-04:0009/26/2024|
Team2024-09-30T16:51:57-04:00Novo CEO Testifies Today on GLP-1 PricesTeam2024-09-30T16:51:57-04:0009/24/2024|
Team2024-09-30T16:49:20-04:00Rare Pediatric Disease PRV Likely to Be Extended via Latest CRTeam2024-09-30T16:49:20-04:0009/23/2024|